Lupus nephritis pathology prediction with clinical indices.

Journal: Scientific reports
Published Date:

Abstract

Effective treatment of lupus nephritis and assessment of patient prognosis depend on accurate pathological classification and careful use of acute and chronic pathological indices. Renal biopsy can provide most reliable predicting power. However, clinicians still need auxiliary tools under certain circumstances. Comprehensive statistical analysis of clinical indices may be an effective support and supplementation for biopsy. In this study, 173 patients with lupus nephritis were classified based on histology and scored on acute and chronic indices. These results were compared against machine learning predictions involving multilinear regression and random forest analysis. For three class random forest analysis, total classification accuracy was 51.3% (class II 53.7%, class III&IV 56.2%, class V 40.1%). For two class random forest analysis, class II accuracy reached 56.2%; class III&IV 63.7%; class V 61%. Additionally, machine learning selected out corresponding important variables for each class prediction. Multiple linear regression predicted the index of chronic pathology (CI) (Q = 0.746, R = 0.771) and the acute index (AI) (Q = 0.516, R = 0.576), and each variable's importance was calculated in AI and CI models. Evaluation of lupus nephritis by machine learning showed potential for assessment of lupus nephritis.

Authors

  • Youzhou Tang
    Nephropathy & Rheumatology Department, 3rd Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Weiru Zhang
    Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Minfeng Zhu
    Hematology Department, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Li Zheng
    School of Environmental Science and Engineering, Institute of Environmental Health and Pollution Control, Guangdong University of Technology, Guangzhou 510006, China.
  • Lingli Xie
    Hematology Department, 3rd Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Zhijiang Yao
    Hematology Department, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Hao Zhang
    College of Mechanical and Electrical Engineering, Henan Agricultural University, Zhengzhou, 450002, China.
  • Dongsheng Cao
    School of Pharmaceutical Sciences, Central South University, Changsha, China. oriental-cds@163.com.
  • Ben Lu
    Hematology Department, The Third Xiangya Hospital, Central South University, Changsha, China.